Epidemiological modelling (including economic modelling) and its role in preventive drug therapy

2002 ◽  
Vol 178 (4) ◽  
pp. 188-189
Author(s):  
Kent R Johnson ◽  
Marissa N Lassere
Keyword(s):  
Drug Therapy ◽  
Economic Modelling ◽  
Epidemiological Modelling ◽  
Preventive Drug

Epidemiological modelling (including economic modelling) and its role in preventive drug therapy

2002 ◽  
Vol 177 (7) ◽  
pp. 364-367 ◽  
Author(s):  
Danny Liew ◽  
John J McNeil ◽  
Anna Peeters ◽  
Stephen S Lim ◽  
Theo Vos
Keyword(s):  
Drug Therapy ◽  
Economic Modelling ◽  
Epidemiological Modelling ◽  
Preventive Drug

In reply: Epidemiological modelling (including economic modelling) and its role in preventive drug therapy

2003 ◽  
Vol 178 (4) ◽  
pp. 188-189
Author(s):  
Danny Liew ◽  
John J McNeil ◽  
Anna Peeters ◽  
Stephen S Lim ◽  
Theo Vos
Keyword(s):  
Drug Therapy ◽  
Economic Modelling ◽  
Epidemiological Modelling ◽  
Preventive Drug

scholarly journals Preventive drug therapy and contralateral breast cancer: summary of the evidence of clinical trials and observational studies

2019 ◽  
Vol 58 (11) ◽  
pp. 1581-1593
Author(s):  
Annet Bens ◽  
Rikke Langballe ◽  
Jonine L. Bernstein ◽  
Deirdre Cronin-Fenton ◽  
Søren Friis ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Trials ◽  
Drug Therapy ◽  
Observational Studies ◽  
Contralateral Breast Cancer ◽  
Contralateral Breast ◽  
Preventive Drug

Meaningful Interpretation of Risk Reduction from Clinical Drug Trials

1993 ◽  
Vol 27 (10) ◽  
pp. 1272-1277 ◽  
Author(s):  
James P. McCormack ◽  
Marc Levine
Keyword(s):  
Drug Therapy ◽  
Relative Risk ◽  
Risk Reduction ◽  
Relative Risk Reduction ◽  
Absolute Risk ◽  
Absolute Risk Reduction ◽  
Preventive Drug ◽  
Prevention Trials ◽  
Intervention Trials ◽  
The Impact

OBJECTIVE: To illustrate the concepts of relative and absolute risk reduction, and by example, present and discuss the results of prevention trials that have evaluated the impact of drug therapy on cardiovascular disease. Additional approaches to evaluating the results of prevention trials are also presented. DATA SOURCES: Data were gathered from eight frequently quoted major cardiovascular intervention trials. CONCLUSIONS: Reference to large reductions in relative risk in review papers, newspapers, and at professional meetings can lead to false expectations among clinicians and patients regarding the potential impact of the treatment in individual patients. When making decisions about preventive drug therapy, clinicians are encouraged to examine measures other than relative risk reduction and to include the patient in the decision process. Educators should emphasize these other measures of outcome and not rely solely on relative risk reduction in discussing particular areas of therapeutics.

Drug Therapy for ‘Prediabetes’ Held Premature

2009 ◽  
Vol 42 (7) ◽  
pp. 26
Author(s):  
MITCHEL L. ZOLER
Keyword(s):  
Drug Therapy
Sign in / Sign up

Export Citation Format

Share Document